The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-13

Study Completion Date

2019-12-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, overall gut health, and markers of inflammation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Food Effects on the Gut Microbiota

NCT03078283

Gut Microbial Responses to Dietary Fiber

COMPLETED NA

The Effect of Whole Grain on Gut Microbiome and Metabolic Health

NCT01731366

Metabolic Disease Injury of Gastrointestinal Tract

UNKNOWN NA

Particle Size Project

NCT05091801

Test if Increased Chewing Will Increased Microbiota SCFA Production

COMPLETED NA

Influence of Freeze Dried Strawberry Consumption on Gut Microbiota and Cardiovascular Health.

NCT03283969

Microbial Colonization Cardiovascular Diseases Obesity

COMPLETED NA

Effects of Changing Intestinal Transit Time on Gut Microbial Composition and Metabolism

NCT06022302

Diet, Healthy Metabolic Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gut Microbiota

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

On the Placebo arm of the intervention, participants will consume a placebo powder.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Placebo will be given in a powder form to mix with a beverage of one's choice.

Dietary Fiber

On the Dietary Fiber arm of the intervention, participants will consume a fiber powder.

Group Type ACTIVE_COMPARATOR

Dietary Fiber

Intervention Type OTHER

Dietary fiber will be given in a powder form to mix with a beverage of one's choice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary Fiber

Dietary fiber will be given in a powder form to mix with a beverage of one's choice.

Intervention Type OTHER

Placebo

Placebo will be given in a powder form to mix with a beverage of one's choice.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy male and female adults 18-45 years old
* BMI: 23.0-32.0 kg/m2 ("overweight")
* Current diet includes low quantity of fiber, defined as less than approximately 15g/day, or equivalent to approximately 4 servings of fruit, vegetable, legume, or whole grain combined per day, and determined using diet recall.
* Willingness to consume prebiotic fiber drink daily for 4 weeks, and a placebo drink for 4 weeks, as well as a 4-week washout period with no intervention.
* Willingness to provide diet records, blood samples and stool samples (self-collected) biweekly for the duration of the study (7 total collections).
* Willingness to adhere to "diet control period" biweekly (eating the same, self-selected foods and abstaining from alcohol each day for 3 days prior to each stool collection/blood draw).
* General bowel movement frequency of at least once every three days and maximum of two times per day.

Exclusion Criteria

* A plan to or desire to lose weight
* Smoker
* Anemia and difficulty with blood draws
* Currently, within previous 6 weeks of the study, or during the study taken probiotic or prebiotic formulations (food products considered to have these properties in their natural or unadulterated forms are acceptable).
* Antibiotic use during the study or within 6 months prior to study commencement.
* Medication: statins, blood pressure medications, other prescription medications
* Pregnant, planning to be pregnant or breast feeding at any point during the study or study enrollment.
* Start or change in use of hormonal birth control in the last 6 months or plans to change or start use of hormonal birth control during the study period
* Allergies to any prebiotic or placebo ingredients - Prebiotic ingredients: Resistant Tapioca Starch, Fructooligosaccharide, Sugarcane Fiber, Agave Inulin, Gum Arabic, Xanthan Gum, Apple Powder, Raspberry Powder, Blueberry Powder / Placebo Blend: Rice Flour, Xanthan Gum, Grape Powder, Plum Powder
* Illness (flu/cold in the last two weeks)
* Documented chronic diseases including diabetes, thyroid disease, metabolic syndrome, hypertension, cancer, or previous cardiovascular events
* Irritable bowel syndrome, celiac disease, or any inflammatory bowel disease (including Crohn's Disease, and/or Ulcerative colitis)
* Any immunosuppression symptoms at any point during the study or study enrollment
* Consumption of \>1 alcoholic drink/day or frequent binge drinking (\>3 alcoholic drinks in one episode) \> 1 day per month
* Plans to change or recent significant changes in lifestyle (e.g. diet or exercise routine, major travel, etc)
* Recent weight fluctuations (greater than 10% in the last six months)
* Regular use of over-the-counter pain medications (\>1/week)
* Taking prescription lipid medications (e.g. statins) or other supplements known to alter lipoprotein metabolism such as isoflavones
* Recent medical procedure such as surgery within the last 6 months
* Any changes in the above during the course of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes